Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events
Risto Kerkelä, Johanna Ulvila, Johanna Magga
Journal of the American Heart Association (2015) Vol. 4, Iss. 10
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Hypertension
Suzanne Oparil, Maria Czarina Acelajado, George L. Bakris, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 887
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Weimar Kunz Sebba Barroso, Cibele Isaac Saad Rodrigues, Luiz Aparecido Bortolotto, et al.
Arquivos Brasileiros de Cardiologia (2021) Vol. 116, Iss. 3, pp. 516-658
Open Access | Times Cited: 794
BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
Zhipeng Cao, Yuqing Jia, Bao-Li Zhu
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1820-1820
Open Access | Times Cited: 289
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Mark Sweeney, Ben Corden, Stuart A. Cook
EMBO Molecular Medicine (2020) Vol. 12, Iss. 10
Open Access | Times Cited: 154
Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation
Pei‐Ling Hsieh, Pei‐Ming Chu, Hui‐Ching Cheng, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10146-10146
Open Access | Times Cited: 73
AAV9:PKP2 improves heart function and survival in a Pkp2-deficient mouse model of arrhythmogenic right ventricular cardiomyopathy
Iris Wu, Aliya Zeng, Amara Greer-Short, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 23
Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis
Hao Zhang, Lei Tian, Mengcheng Shen, et al.
Circulation Research (2019) Vol. 125, Iss. 5, pp. 552-566
Open Access | Times Cited: 145
Long-term neprilysin inhibition — implications for ARNIs
Duncan J. Campbell
Nature Reviews Cardiology (2016) Vol. 14, Iss. 3, pp. 171-186
Closed Access | Times Cited: 131
Novel Risk Markers and Risk Assessments for Cardiovascular Disease
Mark R. Thomas, Gregory Y.H. Lip
Circulation Research (2017) Vol. 120, Iss. 1, pp. 133-149
Open Access | Times Cited: 131
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension
Junichi Omura, Karima Habbout, Tsukasa Shimauchi, et al.
Circulation (2020) Vol. 142, Iss. 15, pp. 1464-1484
Open Access | Times Cited: 128
Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy
Javier Dı́ez
European Journal of Heart Failure (2016) Vol. 19, Iss. 2, pp. 167-176
Open Access | Times Cited: 110
Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
Alexander Е. Berezin, Alexander A. Berezin
Disease Markers (2020) Vol. 2020, pp. 1-21
Open Access | Times Cited: 109
FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
Ineke Böckmann, Jonas Lischka, Beatrice Richter, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4634-4634
Open Access | Times Cited: 89
LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis, and Vasculopathy in a Rat Model of Chronic Kidney Disease
Yasunori Suematsu, Wanghui Jing, Ane Cláudia Fernandes Nunes, et al.
Journal of Cardiac Failure (2018) Vol. 24, Iss. 4, pp. 266-275
Open Access | Times Cited: 85
Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future
Farah Omran, Ioannis Kyrou, Faizel Osman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5680-5680
Open Access | Times Cited: 42
Sacubitril/valsartan in a wide spectrum of heart failure patients (from mechanisms of action to outcomes in specific populations)
Przemyslaw Rajzer, Jan Biegus
Heart Failure Reviews (2025)
Open Access | Times Cited: 1
Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism
Dan Sun, Fei Yang
Biochemical and Biophysical Research Communications (2017) Vol. 486, Iss. 2, pp. 329-335
Closed Access | Times Cited: 66
NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus
Marcus Vinícius Bolívar Malachias, Pardeep S. Jhund, Brian Claggett, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 19
Open Access | Times Cited: 52
Snake Venom Components: Tools and Cures to Target Cardiovascular Diseases
Jacinthe Frangieh, Mohamad Rima, Ziad Fajloun, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2223-2223
Open Access | Times Cited: 46
BNP protects against diabetic cardiomyopathy by promoting Opa1-mediated mitochondrial fusion via activating the PKG-STAT3 pathway
Pan Chang, Xiaomeng Zhang, Jing Zhang, et al.
Redox Biology (2023) Vol. 62, pp. 102702-102702
Open Access | Times Cited: 23
Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
Aleksandra Sobiborowicz, Katarzyna Kamińska, Agnieszka Cudnoch‐Jędrzejewska
Cancers (2023) Vol. 15, Iss. 1, pp. 312-312
Open Access | Times Cited: 17
Recurrence After Atrial Fibrillation Ablation and Investigational Biomarkers of Cardiac Remodeling
Majd El‐Harasis, Joseph A. Quintana, Jose Roberto Martinez‐Parachini, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 6
Open Access | Times Cited: 7
Genetic Dissection of a Super Enhancer Controlling the Nppa-Nppb Cluster in the Heart
Joyce C.K. Man, Karel van Duijvenboden, Peter H.L. Krijger, et al.
Circulation Research (2020) Vol. 128, Iss. 1, pp. 115-129
Open Access | Times Cited: 45
Advantages and Disadvantages of Different Treatment Methods in Achondroplasia: A Review
Wiktoria Wrobel, E Pach, Iwona Beń‐Skowronek
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5573-5573
Open Access | Times Cited: 33
Residues of Cardiovascular and Lipid-Lowering Drugs Pose a Risk to the Aquatic Ecosystem despite a High Wastewater Treatment Ratio in the Megacity Shanghai, China
Shaoqi Zuo, Haoyu Meng, Jiahui Liang, et al.
Environmental Science & Technology (2022) Vol. 56, Iss. 4, pp. 2312-2322
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top